Medical Imaging Corporation (TPEX:6637)
Taiwan · Delayed Price · Currency is TWD 54.00
-0.20 (-0.37%)
Sep 10, 2026, 1:30 PM CST
Medical Imaging Market Cap
Medical Imaging has a market cap or net worth of 1.45 billion as of September 10, 2026. Its market cap has decreased by -34.94% in one year.
Market Cap
1.45B
Enterprise Value
1.42B
Revenue
915.34M
Ranking
n/a
PE Ratio
9.87
Stock Price
54.00
ChartMarket Cap Chart
Since June 26, 2017, Medical Imaging's market cap has increased from 1.01B to 1.45B, an increase of 43.74%. That is a compound annual growth rate of 4.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2026 | 1.45B | -30.50% |
| Dec 31, 2025 | 2.08B | -9.23% |
| Dec 31, 2024 | 2.29B | 28.90% |
| Dec 29, 2023 | 1.78B | 70.43% |
| Dec 30, 2022 | 1.04B | 18.20% |
| Dec 30, 2021 | 883.74M | -26.82% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 25, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 26, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 547.05B |
| Lin BioScience | 139.31B |
| Caliway Biopharmaceuticals | 133.14B |
| Pell Bio-Med Technology | 71.94B |
| Taiwan Biomaterial | 1.50B |
| Advagene Biopharma | 1.43B |
| TaiRx | 1.42B |
| Andros Pharmaceuticals Co.,Ltd | 1.39B |